{"id":"sham-treatment","safety":{"commonSideEffects":[{"rate":null,"effect":"Placebo effect (perceived symptom improvement without active agent)"}]},"_chembl":{"chemblId":"CHEMBL7257","moleculeType":"Small molecule","molecularWeight":"218.30"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Sham treatment refers to an inert or inactive intervention used as a control in clinical trials and research studies. It is designed to mimic the appearance and administration of an active treatment while containing no therapeutic agent, allowing researchers to isolate the true effect of an investigational drug from placebo effects.","oneSentence":"Sham treatment is a placebo control intervention with no active pharmacological mechanism.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:37:29.620Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Used as control in clinical research across all therapeutic areas"}]},"trialDetails":[{"nctId":"NCT07496021","phase":"NA","title":"Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease","status":"RECRUITING","sponsor":"CKD Bio Corporation","startDate":"2026-02-23","conditions":"Early Alzheimers Disease","enrollment":60},{"nctId":"NCT06735599","phase":"NA","title":"Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure","status":"RECRUITING","sponsor":"Georgia State University","startDate":"2024-09-17","conditions":"Hypertension (Without Type 2 Diabetes Mellitus), High Blood Pressure, Male","enrollment":40},{"nctId":"NCT07135232","phase":"NA","title":"The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health.","status":"RECRUITING","sponsor":"Leeds Beckett University","startDate":"2026-03-01","conditions":"Perimenopause, Menopause","enrollment":72},{"nctId":"NCT06097663","phase":"PHASE2","title":"A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2024-02-15","conditions":"Coronary Heart Disease, Clonal Hematopoiesis of Indeterminate Potential (CHIP)","enrollment":31},{"nctId":"NCT06868914","phase":"PHASE1","title":"Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)","status":"NOT_YET_RECRUITING","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2026-04-01","conditions":"Healthy Volunteers","enrollment":35},{"nctId":"NCT06806592","phase":"PHASE3","title":"A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases","status":"RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2025-09-13","conditions":"Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases","enrollment":400},{"nctId":"NCT07496645","phase":"PHASE3","title":"EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION ON NAMING IN APHASIC PATIENTS WITH ACUTE ISCHEMIC STROKE","status":"NOT_YET_RECRUITING","sponsor":"Dr. Ram Manohar Lohia Hospital","startDate":"2026-03-31","conditions":"Acute Ischemic Cerebrovascular Disease, Post Stroke Aphasia, Aphasia Following Cerebral Infarction","enrollment":28},{"nctId":"NCT05546554","phase":"PHASE2","title":"Trial of Suvorexant for Sleep in Children With Autism","status":"RECRUITING","sponsor":"Stanford University","startDate":"2023-08-09","conditions":"Autism, Autism Spectrum Disorder","enrollment":26},{"nctId":"NCT07485959","phase":"NA","title":"The Effect of NP-2006 on Sleep Quality and Health","status":"COMPLETED","sponsor":"Hanpoong Nature Pharm Co., Ltd.","startDate":"2023-05-12","conditions":"Sleep Disorder (Disorder)","enrollment":48},{"nctId":"NCT07494279","phase":"NA","title":"Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype","status":"NOT_YET_RECRUITING","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2026-03-30","conditions":"Prehypertension, Hypertension","enrollment":106},{"nctId":"NCT07433556","phase":"PHASE1","title":"Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of IY-828026 in Healthy Volunteers","status":"RECRUITING","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2026-03-23","conditions":"Healhty","enrollment":86},{"nctId":"NCT06817356","phase":"PHASE2","title":"A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2025-02-06","conditions":"Alcohol Use Disorder","enrollment":300},{"nctId":"NCT07498127","phase":"PHASE2","title":"Effects of Probiotics on Respiratory Tract Infections in Children: A Randomized, Placebo-Controlled Interventional Study","status":"ENROLLING_BY_INVITATION","sponsor":"Min-Tze LIONG","startDate":"2026-02-01","conditions":"URTI","enrollment":120},{"nctId":"NCT07495202","phase":"PHASE1","title":"A Clinical Trial Evaluating the Monkeypox Recombinant Protein Vaccine","status":"NOT_YET_RECRUITING","sponsor":"Shanghai JunTop Biosciences Co., LTD","startDate":"2026-03-30","conditions":"Health Volunteer","enrollment":180},{"nctId":"NCT07037433","phase":"PHASE3","title":"Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity","status":"RECRUITING","sponsor":"Amgen","startDate":"2025-07-25","conditions":"Atherosclerotic Cardiovascular Disease, Overweight, Obesity","enrollment":12800},{"nctId":"NCT07498569","phase":"NA","title":"Effects of Percutaneous Electrical Stimulation in Patients With Chronic Supraspinatus Tendinopathy","status":"NOT_YET_RECRUITING","sponsor":"Universidad Miguel Hernandez de Elche","startDate":"2026-09-01","conditions":"Supraspinatus Tendinopathy","enrollment":64},{"nctId":"NCT07498166","phase":"NA","title":"Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-02-01","conditions":"Achilles Tendon Rupture, Blood Flow Restriction Therapy, Achilles Tendon Repairs/Reconstructions","enrollment":75},{"nctId":"NCT06030362","phase":"NA","title":"Probiotic Intervention Study","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2023-07-18","conditions":"Obesity, Food Addiction","enrollment":100},{"nctId":"NCT07494305","phase":"PHASE2","title":"Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.","status":"RECRUITING","sponsor":"LB Pharmaceuticals Inc.","startDate":"2026-01-23","conditions":"Bipolar I Disorder","enrollment":320},{"nctId":"NCT06787079","phase":"NA","title":"Effect of Kinesio Taping Application in Addition to Pilates Exercises on Core Muscle Thickness, Cognition and Mental Fatigue in Individuals With Non-specific Low Back Pain","status":"COMPLETED","sponsor":"Istanbul Saglik Bilimleri University","startDate":"2025-05-01","conditions":"Low Back Pain, Non Specific Low Back Pain","enrollment":54},{"nctId":"NCT05377424","phase":"PHASE1, PHASE2","title":"Adenosine 2A Receptor Antagonism and AIH in ALS","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2022-06-21","conditions":"ALS","enrollment":40},{"nctId":"NCT07420218","phase":"PHASE4","title":"Menopausal Hormones and Sympathetic Activation","status":"NOT_YET_RECRUITING","sponsor":"University of Delaware","startDate":"2026-09-01","conditions":"Perimenopausal Women","enrollment":80},{"nctId":"NCT05754957","phase":"PHASE3","title":"A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-04-07","conditions":"Acute Coronary Syndrome","enrollment":14194},{"nctId":"NCT07497932","phase":"NA","title":"Nutritional Effects in Cardiovascular Surgery","status":"RECRUITING","sponsor":"Fu Jen Catholic University","startDate":"2026-03-19","conditions":"Cardiovascular Surgery, Cardiovascular Disease","enrollment":30},{"nctId":"NCT06450444","phase":"NA","title":"The RECLAIM Study.","status":"RECRUITING","sponsor":"Salvia BioElectronics","startDate":"2024-06-24","conditions":"Chronic Migraine, High Frequency Episodic Migraine","enrollment":110},{"nctId":"NCT05241041","phase":"NA","title":"Effects of Positive Psychological Group Psychotherapy and Auricular Acupressure on Withdrawal Symptoms","status":"COMPLETED","sponsor":"Inha University Hospital","startDate":"2021-09-13","conditions":"Gambling","enrollment":198},{"nctId":"NCT07495176","phase":"NA","title":"USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias","status":"COMPLETED","sponsor":"Shanghai Children's Hospital","startDate":"2021-02-01","conditions":"Hypospadias","enrollment":82},{"nctId":"NCT06972446","phase":"PHASE2","title":"A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-06-20","conditions":"Rheumatoid Arthritis","enrollment":180},{"nctId":"NCT07072468","phase":"PHASE2","title":"Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)","status":"RECRUITING","sponsor":"VM Therapeutics LLC","startDate":"2025-12-12","conditions":"Chemotherapy-induced Peripheral Neuropathy, Drug-Induced Nephropathy","enrollment":16},{"nctId":"NCT07496450","phase":"PHASE3","title":"A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults","status":"RECRUITING","sponsor":"ModernaTX, Inc.","startDate":"2026-03-23","conditions":"Influenza","enrollment":4000},{"nctId":"NCT07427680","phase":"PHASE1, PHASE2","title":"Study of TGM-312-SC01 in Healthy Participants and Adults With MASH","status":"RECRUITING","sponsor":"Tangram Therapeutics Plc","startDate":"2026-02","conditions":"Healthy Participants, MASH - Metabolic Dysfunction-Associated Steatohepatitis","enrollment":99},{"nctId":"NCT07497113","phase":"NA","title":"The Effects of Commercially Available High Protein Drink on Amino Acid Bioavailability and Recovery From Muscle Fatiguing Exercise in 18-45-year-old Male and Female Participants.","status":"COMPLETED","sponsor":"Anglia Ruskin University","startDate":"2025-03-01","conditions":"Healthy Participants","enrollment":62},{"nctId":"NCT07498660","phase":"NA","title":"PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomized Trial)","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2026-04-01","conditions":"Osteoarthitis, Sacro Iliac Joint Pain, Hip Arthroplasty, Total","enrollment":60},{"nctId":"NCT05791604","phase":"NA","title":"The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2023-04-01","conditions":"Prader-Willi Syndrome","enrollment":60},{"nctId":"NCT06898606","phase":"PHASE1, PHASE2","title":"Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression","status":"RECRUITING","sponsor":"Federal University of Latin American Integration","startDate":"2024-09-05","conditions":"Depressive Disorder","enrollment":24},{"nctId":"NCT06456346","phase":"PHASE3","title":"Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-07-16","conditions":"Essential Thrombocythemia","enrollment":300},{"nctId":"NCT05718375","phase":"PHASE2","title":"Phase IIb Clinical Trial for the Efficacy and Safety by CU01-1001 for 24 Weeks in Type 2 DM Patients With Albuminuria","status":"COMPLETED","sponsor":"Curacle Co., Ltd.","startDate":"2023-02-14","conditions":"Diabetic Nephropathies","enrollment":240},{"nctId":"NCT07431086","phase":"PHASE2","title":"Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2026-03-16","conditions":"Overweight or Obesity","enrollment":120},{"nctId":"NCT05855824","phase":"NA","title":"Toddler Biomarker of Nutrition Study","status":"NOT_YET_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2026-06-01","conditions":"Pediatric Nutrition, Nutrition, Healthy","enrollment":150},{"nctId":"NCT05462730","phase":"PHASE2","title":"Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction","status":"COMPLETED","sponsor":"Thomas Engstrom","startDate":"2022-11-14","conditions":"ST Elevation Myocardial Infarction, Inflammatory Response, Myocardial Reperfusion Injury","enrollment":530},{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":"Pre-Gestational Diabetes","enrollment":137},{"nctId":"NCT04050410","phase":"EARLY_PHASE1","title":"Autonomic Determinants of POTS - Pilot1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2019-08-27","conditions":"Postural Tachycardia Syndrome","enrollment":48},{"nctId":"NCT07149649","phase":"PHASE2, PHASE3","title":"Magnesium Supplementation in Advanced Non-small Cell Lung Cancer (NSCLC)","status":"NOT_YET_RECRUITING","sponsor":"Swiss Cancer Institute","startDate":"2026-07","conditions":"Metastatic NSCLC - Non-Small Cell Lung Cancer","enrollment":230},{"nctId":"NCT06869447","phase":"NA","title":"New York Better Breathing Study","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2026-04-15","conditions":"Localized Lung Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8","enrollment":100},{"nctId":"NCT07116109","phase":"NA","title":"Neuromodulation + Prolonged Exposure Therapy: Evaluation of a Technology-Enhanced, Integrated Treatment for Pain and PTSD","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-07-01","conditions":"Chronic Pain, Post Traumatic Stress Disorder (PTSD)","enrollment":146},{"nctId":"NCT07498309","phase":"PHASE3","title":"Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell Disease","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2026-09","conditions":"Vaso-Occlusive Crises, Sickle Cell Disease","enrollment":144},{"nctId":"NCT06949969","phase":"NA","title":"Alesis OSA-1 Obstructive Sleep Apnea Treatment","status":"COMPLETED","sponsor":"Photonica USA, LLC","startDate":"2025-05-01","conditions":"Obstructive Sleep Apnea","enrollment":35},{"nctId":"NCT07495813","phase":"PHASE1","title":"A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2026-03-31","conditions":"Stable Coronary Artery Disease, Healthy Volunteers","enrollment":196},{"nctId":"NCT02392442","phase":"PHASE2","title":"Effects of Bronchial Segmental Endotoxin Instillation in Humans","status":"ENROLLING_BY_INVITATION","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2015-06-18","conditions":"Acute Lung Inflammation","enrollment":58},{"nctId":"NCT07495254","phase":"NA","title":"Effectiveness of Combined Super Inductive System (SIS) Therapy With Therapeutic Exercise and Health Education in Lateral Elbow Tendinopathy","status":"NOT_YET_RECRUITING","sponsor":"University of Vic - Central University of Catalonia","startDate":"2026-03-30","conditions":"Lateral Epicondylitis (Tennis Elbow), Lateral Epicondylalgia, Lateral Elbow Tendinopathy","enrollment":224},{"nctId":"NCT07046819","phase":"PHASE2","title":"Tirzepatide in MetALD","status":"NOT_YET_RECRUITING","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2026-04-01","conditions":"Metabolic Alcohol-associated Liver Disease, Alcohol Use Disorder","enrollment":120},{"nctId":"NCT04544449","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2020-10-26","conditions":"Multiple Sclerosis, Primary Progressive","enrollment":985},{"nctId":"NCT03375320","phase":"PHASE3","title":"Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-10-26","conditions":"Functioning Pancreatic Neuroendocrine Tumor, Intermediate Grade Lung Neuroendocrine Neoplasm, Locally Advanced Digestive System Neuroendocrine Neoplasm","enrollment":298},{"nctId":"NCT04669158","phase":"PHASE1, PHASE2","title":"Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis","status":"COMPLETED","sponsor":"Stanford University","startDate":"2021-07-30","conditions":"Non Alcoholic Steatohepatitis, Fibrosis","enrollment":53},{"nctId":"NCT07220785","phase":"PHASE3","title":"Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2026-03-13","conditions":"Generalized Lipodystrophy","enrollment":28},{"nctId":"NCT05752032","phase":"","title":"A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo","status":"ENROLLING_BY_INVITATION","sponsor":"ICM Co. Ltd.","startDate":"2023-03-16","conditions":"Osteoarthritis, Knee","enrollment":16},{"nctId":"NCT04199104","phase":"PHASE3","title":"A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-05","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":511},{"nctId":"NCT05077904","phase":"PHASE3","title":"A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures","status":"RECRUITING","sponsor":"UCB Biopharma SRL","startDate":"2021-12-07","conditions":"Stereotypical Prolonged Seizures","enrollment":350},{"nctId":"NCT05223036","phase":"PHASE2","title":"Testing Obeticholic Acid for Familial Adenomatous Polyposis","status":"SUSPENDED","sponsor":"National Cancer Institute (NCI)","startDate":"2023-01-19","conditions":"Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma, Duodenal Carcinoma","enrollment":80},{"nctId":"NCT05499130","phase":"PHASE2","title":"A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2022-09-30","conditions":"Crohn Disease, Colitis, Ulcerative","enrollment":290},{"nctId":"NCT06044935","phase":"NA","title":"Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2024-01-08","conditions":"Overweight, Obesity","enrollment":100},{"nctId":"NCT04238676","phase":"PHASE1, PHASE2","title":"Persica 002 Phase 1b PP353 vs Placebo in the Treatment of Low Back Pain","status":"COMPLETED","sponsor":"Persica Pharmaceuticals Ltd","startDate":"2020-01-20","conditions":"Chronic Low-back Pain","enrollment":43},{"nctId":"NCT07491302","phase":"PHASE2","title":"Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection","status":"NOT_YET_RECRUITING","sponsor":"Goed Medisch Centrum","startDate":"2026-03","conditions":"Thumb Osteoarthritis","enrollment":88},{"nctId":"NCT05594862","phase":"NA","title":"Treatment of Crohn's Complex Perianal Fistulas With Tissue Transplantation by Local Injection of Micro-fragmented Autologous Adipose Tissue.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Lipogems International spa","startDate":"2023-01-09","conditions":"Crohn Disease","enrollment":80},{"nctId":"NCT03049462","phase":"PHASE1","title":"The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists","status":"RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2017-03-13","conditions":"Polycystic Ovary Syndrome","enrollment":100},{"nctId":"NCT05652504","phase":"PHASE1","title":"Safety Evaluation of PfSPZ Vaccine in Pregnant Women in Mali (MalVIP1)","status":"SUSPENDED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-04-01","conditions":"Malaria","enrollment":400},{"nctId":"NCT07235917","phase":"PHASE2","title":"A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea","status":"RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2026-03-11","conditions":"Functional Hypothalamic Amenorrhea (FHA)","enrollment":34},{"nctId":"NCT06665074","phase":"PHASE2","title":"Inflammatory Challenge in Human Aggression.","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2026-02-16","conditions":"Intermittent Explosive Disorder","enrollment":112},{"nctId":"NCT07285018","phase":"PHASE2","title":"A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain","status":"RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2026-02-16","conditions":"Diabetic Peripheral Neuropathic Pain","enrollment":150},{"nctId":"NCT07498712","phase":"NA","title":"Effect of L. Reuteri LM1063 on Sleep Health Improvement","status":"RECRUITING","sponsor":"Lactomason Co., Ltd.","startDate":"2025-07-14","conditions":"Sleep Quality, Sleep Wake Disorders","enrollment":80},{"nctId":"NCT06631287","phase":"PHASE3","title":"Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID","status":"RECRUITING","sponsor":"Wes Ely","startDate":"2024-10-21","conditions":"Long COVID, Sars-CoV-2 Infection, Coronavirus Infections","enrollment":550},{"nctId":"NCT06344104","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2024-04-08","conditions":"Uncontrolled Hypertension, Resistant Hypertension","enrollment":326},{"nctId":"NCT04732325","phase":"NA","title":"Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2021-09-11","conditions":"Chronic Pain, Failed Back Surgery Syndrome, Complex Regional Pain Syndromes","enrollment":34},{"nctId":"NCT05528718","phase":"","title":"SMILE Trial - Imaging Sub-Study","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2023-03-07","conditions":"Major Depressive Disorder","enrollment":11},{"nctId":"NCT06564818","phase":"PHASE3","title":"\"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder\"","status":"RECRUITING","sponsor":"Cybin IRL Limited","startDate":"2024-12-17","conditions":"Major Depressive Disorder","enrollment":220},{"nctId":"NCT06412666","phase":"PHASE2, PHASE3","title":"A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).","status":"RECRUITING","sponsor":"Cytokinetics","startDate":"2024-05-29","conditions":"Pediatric, Symptomatic Obstructive Hypertrophic Cardiomyopathy","enrollment":55},{"nctId":"NCT07419828","phase":"PHASE3","title":"A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease","status":"RECRUITING","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2026-03-13","conditions":"Chronic Kidney Disease","enrollment":1978},{"nctId":"NCT05713799","phase":"PHASE2","title":"Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2026-04-01","conditions":"Insulin Resistance, Obesity","enrollment":60},{"nctId":"NCT02443077","phase":"PHASE3","title":"Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-10-12","conditions":"Recurrent Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Refractory Diffuse Large B-Cell Lymphoma Activated B-Cell Type","enrollment":94},{"nctId":"NCT06464146","phase":"PHASE3","title":"Pain Reduction for Limb Injuries in Pediatric Emergency Departments: Intranasal Fentanyl or Intranasal Ketamine vs Oral Morphine","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-02-26","conditions":"Limb Injury","enrollment":300},{"nctId":"NCT02965703","phase":"PHASE2","title":"Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-01-16","conditions":"Colorectal Adenoma, Colorectal Carcinoma","enrollment":81},{"nctId":"NCT03354741","phase":"NA","title":"Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2019-05-23","conditions":"Children, Chemotherapy-induced Nausea and Vomiting, Malignant Tumor","enrollment":30},{"nctId":"NCT07008586","phase":"NA","title":"The Impact of OliPhenolia® Supplementation on Exercise Induced Inflammation and Functional Movement in Humans.","status":"COMPLETED","sponsor":"Anglia Ruskin University","startDate":"2025-07-01","conditions":"Healthy","enrollment":18},{"nctId":"NCT07495852","phase":"PHASE3","title":"Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant","status":"RECRUITING","sponsor":"Glaukos Corporation","startDate":"2026-02-17","conditions":"Glaucoma","enrollment":510},{"nctId":"NCT06745921","phase":"PHASE1","title":"Safety and Immunogenicity of an Inactivated West Nile Virus Vaccine in Healthy Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-02-24","conditions":"West Nile Viral Infection","enrollment":30},{"nctId":"NCT05327127","phase":"PHASE2","title":"Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kowa Research Institute, Inc.","startDate":"2022-11-14","conditions":"NASH","enrollment":228},{"nctId":"NCT03646175","phase":"NA","title":"Choline Supplementation and Cardiovascular Health","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2018-09-24","conditions":"Cardiovascular Risk Factor","enrollment":29},{"nctId":"NCT06196879","phase":"PHASE2","title":"A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)","status":"COMPLETED","sponsor":"Upstream Bio Inc.","startDate":"2024-02-27","conditions":"Severe Asthma","enrollment":479},{"nctId":"NCT05009862","phase":"PHASE4","title":"The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2022-04-19","conditions":"Peripheral Arterial Disease","enrollment":60},{"nctId":"NCT07210723","phase":"PHASE2, PHASE3","title":"A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy","status":"RECRUITING","sponsor":"Kardigan, Inc.","startDate":"2026-02-13","conditions":"Symptomatic Genetic Dilated Cardiomyopathy","enrollment":332},{"nctId":"NCT06072183","phase":"PHASE3","title":"A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"Pfizer","startDate":"2023-11-08","conditions":"Stable Nonsegmental Vitiligo, Active Nonsegmental Vitiligo","enrollment":1571},{"nctId":"NCT03969004","phase":"PHASE3","title":"Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Regeneron Pharmaceuticals","startDate":"2019-06-04","conditions":"Cutaneous Squamous Cell Carcinoma","enrollment":415},{"nctId":"NCT07498140","phase":"NA","title":"Procedural Framing and Epidural Steroid Injection Outcomes","status":"RECRUITING","sponsor":"Northwestern University","startDate":"2026-03-25","conditions":"Lumbosacral Radiculopathy","enrollment":210},{"nctId":"NCT05720884","phase":"NA","title":"Acupuncture for Blood Pressure Fluctuation During Total Laparoscopic Hysterectomy","status":"COMPLETED","sponsor":"Ilsan Cha hospital","startDate":"2023-10-23","conditions":"Total Laparoscopic Hysterectomy","enrollment":35},{"nctId":"NCT07037771","phase":"PHASE3","title":"A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)","status":"RECRUITING","sponsor":"Arrowhead Pharmaceuticals","startDate":"2025-06-17","conditions":"Homozygous Familial Hypercholesterolemia","enrollment":60},{"nctId":"NCT07497087","phase":"PHASE3","title":"A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2026-06-09","conditions":"Systemic Sclerosis","enrollment":448},{"nctId":"NCT07266831","phase":"PHASE2, PHASE3","title":"A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-12-18","conditions":"Human Immunodeficiency Virus Type 1 (HIV-1) Infection","enrollment":570},{"nctId":"NCT06128629","phase":"PHASE3","title":"MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)","status":"RECRUITING","sponsor":"Intellia Therapeutics","startDate":"2023-12-13","conditions":"Transthyretin Amyloidosis (ATTR) With Cardiomyopathy","enrollment":1200},{"nctId":"NCT05531565","phase":"PHASE2, PHASE3","title":"A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus","status":"RECRUITING","sponsor":"Biogen","startDate":"2022-09-13","conditions":"Subacute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus","enrollment":450},{"nctId":"NCT06757764","phase":"PHASE4","title":"The Effect and Safety of Combined Anti-platelet Treatment in Acute Ischemic Stroke Due to Large Artery Atherosclerosis","status":"RECRUITING","sponsor":"Asan Medical Center","startDate":"2025-07-10","conditions":"Cerebral Infarction, Stenosis Artery","enrollment":2340}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"EAR INFECTION"},{"count":2,"reaction":"FALL"},{"count":1,"reaction":"ACUTE KIDNEY INJURY"},{"count":1,"reaction":"ANGINA PECTORIS"},{"count":1,"reaction":"GASTROINTESTINAL HAEMORRHAGE"},{"count":1,"reaction":"HIP FRACTURE"},{"count":1,"reaction":"RIB FRACTURE"},{"count":1,"reaction":"SUBDURAL HAEMATOMA"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["saline","ambient air","1.2 ATA then changed to 1.0 ATA","Control group","Saline solution and general anesthesia"],"phase":"marketed","status":"active","brandName":"Sham treatment","genericName":"Sham treatment","companyName":"RTI International","companyId":"rti-international","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Sham treatment is a placebo control intervention with no active pharmacological mechanism. Used for Used as control in clinical research across all therapeutic areas.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":19,"withResults":3},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}